<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with cerebral dural sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (CST) following <z:chebi fb="2" ids="27899">cisplatin</z:chebi> therapy are presented </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="2" ids="27899">Cisplatin</z:chebi> is a well-recognized risk factor for <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> and <z:mp ids='MP_0005048'>thrombosis</z:mp>, but is not known to be associated with CST </plain></SENT>
<SENT sid="2" pm="."><plain>Clinicians should be aware of the potential risk for the development of CST following <z:chebi fb="2" ids="27899">cisplatin</z:chebi> therapy </plain></SENT>
</text></document>